New brain scan could spot Alzheimer's earlier

NCT ID NCT05336695

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a special PET scan can measure a protein called fibrin in the brains of people with Alzheimer's disease. Researchers will scan 30 volunteers, including healthy older adults and those with Alzheimer's, to see if fibrin levels differ. The goal is to improve diagnosis and understanding of the disease.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

64Cu-FBP8 (a radioactive dye for PET scans)

What this could lead to

If successful, this could lead to a new way to detect Alzheimer's disease earlier and more accurately using brain scans.

What could go wrong

This is an early-phase study with only 30 participants, so results may not apply widely. The dye is experimental and may not clearly show differences between healthy and affected brains.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Alzheimer disease dementia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Massachusetts General Hospital

    RECRUITING

    Boston, Massachusetts, 02115, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact